Promethazine

Recommendations for the treatment of common viral upper respiratory tract infections (URTIs) in children have undergone significant changes over the past 10 years. In 2008, the FDA and the AAP recommended avoiding over-the-counter products for the treatment of URTI symptoms, including cough/cold (C/C), in young children. These products should be avoided in children aged younger than 4 years, and the AAP cautions about their use in children aged 4 to 6 years and only when the child is receiving care from a provider.